Sector revisions Cipla Limited

Stocks

Market Closed - NSE India S.E. 12:05:07 16/09/2026 BST			5-day change	1st Jan Change
1,358.00 ^INR	+0.52%		-1.88%	-10.14%

09-03	India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar	RE
08-25	Cipla's Pithampur, India Unit Gets 7 Observations From US FDA	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
CIPLA LIMITED					36
SUN PHARMACEUTICAL INDUSTRIES LTD.					33
OTSUKA HOLDINGS CO., LTD.					12
ZYDUS LIFESCIENCES LIMITED					30
KRKA, D. D.					6
GEDEON RICHTER					7
GLENMARK PHARMACEUTICALS LIMITED					11
ONO PHARMACEUTICAL CO., LTD.					12
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.				-	-
AJANTA PHARMA LIMITED					13
ASPEN PHARMACARE HOLDINGS LIMITED					3
SIMCERE PHARMACEUTICAL GROUP LIMITED					4
ASTRA INDUSTRIAL GROUP COMPANY					2
SUNSHINE LAKE PHARMA CO., LTD.	-	-		-	-
JAMJOOM PHARMACEUTICALS FACTORY COMPANY					4
HAW PAR CORPORATION LIMITED		-	-	-	1
APICHOPE PHARMACEUTICAL GROUP CO., LTD.				-	-
CAPLIN POINT LABORATORIES LIMITED					2
Average					12
Weighted average by Cap.					19